DUBLIN, March 5, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein and Glycoengineered Antibodies Market" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through introduction of modifications in monoclonal antibodies, the aim is to develop antibodies with improved efficacy.
Research done in the last decade to develop engineered antibodies has yielded a rich knowledge base on how to develop and market these next generation antibodies. These therapeutic antibodies seem to be more promising, with improved properties when compared to their ancestors. There are several molecules in phase II / III clinical trials and a few waiting for approvals. In addition, a large number of molecules are also in pre-clinical trials and are expected to progress through various stages of drug development over the next ten years.
The Fc Protein and Glycoengineered Antibody Market, 2013-2023 report was commissioned to examine the various aspects of engineering an antibody to develop novel drugs and address several oncology specific diseases. With the market being fairly new, the report examines several elements of developing these next generation antibodies including technologies used for their production, site of engineering in an antibody and molecules in pipeline.
For the purposes of this report, engineered antibodies are defined as antibodies which have been modified in their Fc region. The two types of modification considered are:
Key Topics Covered:
1. EXECUTIVE SUMMARY
2. INTRODUCTION
3. ENGINEERED ANTIBODIES: OVERVIEW AND BACKGROUND
4. GLYCOENGINEERED ANTIBODIES MARKET, 2012 - 2023
5. Fc PROTEIN ENGINEERED ANTIBODIES MARKET, 2013 - 2023
6. TECHNOLOGICAL PLATFORMS FOR ENGINEERED ANTIBODIES
7. PROFILES OF LEADING COMPANIES
8. SWOT ANALYSIS
9. CONCLUSIONS
10. APPENDIX 1: TABLES
11. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article